Navigation Links
LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation

LifeCycle Pharma has established a Scientific Advisory Board for its transplantation programs. In addition, LifeCycle Pharma announces the expansion of its United States (U.S.) clinical development department with the addition of Drs. Rob Gordon and Larry Chodoff LifeCycle Pharma A/S OMX:LCP) today announced the formation of an international Scientific Advisory Board (SAB) of experts in the field of organ transplantation. The SAB will provide counsel to the company's management team as LifeCycle Pharma expands its development programs within the area of solid organ transplantation.

The SAB consists of six internationally recognized thought leaders from the U.S. and Europe, including:

Dr. Rita R. Alloway, Director of Transplant Clinical Research, University of Cincinnati
Dr. Klemens Budde, Medical Director of Transplantation, Charite University Hospital, Berlin
Dr. Robert S. Gaston, Medical Director of Kidney & Pancreas Transplantation, University of Alabama, Birmingham
Dr. Josep M. Grinyo, Chief, Division of Nephrology, University Hospital of Bellvitge, Barcelona
Dr. John R. Lake, Director, Gastroenterology Division, University of Minnesota, Minneapolis
Dr. Marc D. Pescovitz, Professor of Surgery and Microbiology/Immunology, Indiana University Medical Center, Indianapolis

'As LifeCycle Pharma advances its product portfolio within organ transplantation, the Scientific Advisory Board will provide an instrumental role in guiding our research and development programs,' said Dr. Flemming Ornskov, President and CEO of LifeCycle. 'We have attracted established, and highly respected members of the transplantation field who will play a pivotal role in LifeCycle Pharma bringing innovation to this disease area,' added Dr.Orsnkov.

In addition, LifeCycle Pharma has strengthened its clinical development capabilities in the U.S. with the addition of Drs. Robe rt Gordon, as Senior Director of Medical and Clinical Research, and Larry Chodoff, as Director of Medical Affairs Transplantation.

Dr. Gordon is an internationally respected transplant surgeon who has spent more then 30 years in academia and industry. He was a member of the team that was headed by the world renowned transplant surgeon, Dr. Thomas Starzl, at the University of Colorado and the University of Pittsburgh. From 1992 until he moved to industry, Dr. Gordon was Professor of Surgery and Director of the Liver Transplant Service at Emory University Hospital in Atlanta, Georgia. Most recently, Dr. Gordon was the Senior Medical Director for Transplantation at Roche Laboratories in Nutley, New Jersey.

After 17 years of practice at the Mount Sinai Medical Center in New York, New York, Dr. Larry Chodoff joined Novartis Pharmaceuticals Corporation in 1997, as Associate Director of Clinical Research, managing global research and development programs in organ transplantation and autoimmune diseases.

Prior to joining LifeCycle Pharma, Dr. Chodoff held the position of Medical Liaison in Transplantation and Immunology at Roche Laboratories. Dr. Chodoff received his Pharm.D. from the University of the Pacific School of Pharmacy in 1979.

'Their combined experience of more than 50 years of working within the area of organ transplantation will be a great asset for LifeCycle Pharma as our LCP-Tacro program enters Phase II clinical trials,' said Dr. Michael Beckert, Chief Medical Officer at LifeCycle Pharma, who will oversee the responsibilities of Drs. Rob Gordon and Larry Chodoff.




'"/>




Related medicine news :

1. LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-Tacro for Organ Transplantation
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharma cos must forge Strategic alliances
5. Medicis Pharmaceutical company enters pediatric market
6. Pharma majors gear to supply anti-anthrax drug
7. Pharmacies in for a dose of bitter medicine
8. Andhra Pradesh to set up Pharma City
9. Sun Pharma to launch chiral version of omeprazole soon
10. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
11. Pharmacia may take 51.5 percent Abbott stake
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology: